Regulatory Science & Product Development Experts helping customers
Commercialise Products | Reduce Time to Market | Achieve Compliance | Grow Business
Experience
Vyomus Consulting understands the science behind your product, applicable regulations and expected business outcomes, to help customers formulate and implement regulatory and development strategies for Pharmaceuticals, Biopharmaceuticals, Medical Devices, Cosmetics, Food & Nutritional products, right from lead candidate/prototype selection to final regulatory submissions leading to more effective and efficient product commercialisation.
Vyomus Consulting developed and well tested implementation methodology – “ASIA” generates significant business gains on all implemented projects. It integrates science, regulations and measurable business outcomes, at each stage of the product development lifecycle to ensure a focus on results for both business and functional stakeholders. The business consulting approach and impeccable process implementation and delivery practices ensure that optimal product development solutions are implemented to achieve specified business objectives, strategically.
Integrating Science, Regulations, Measurable Business outcomes and combining local knowledge with global standards, we move beyond providing expert advice to get your project off the ground, move at a fast pace and achieve faster approvals.
Vyomus Consulting senior practitioners have a unique blend of business, domain, technology and pharma process outsourcing expertise and include former senior executives from top Pharma, Biotechnology, Clinical Development companies, top tier consultancies, Fortune 500 enterprises, and leading outsourcing service providers.
In existence since 2008, we have worked with various regional and global Pharmaceuticals, Biopharmaceuticals, Medical Devices, Cosmetics, Food & Nutritional customers to deliver our commitments.
Our overall experience includes over six hundred preclinical, clinical trial approvals, product registrations, marketing authorizations, import and marketing authorizations, manufacturing and marketing authorization and transactions covering a large number of therapeutic and product categories.
